Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

A wave of diagnostic tests—some here, some coming—can identify cancer and Alzheimer’s at earlier stages and predict flare-ups ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...

A first-of-its-kind blood test developed by Malvern-based Fujirebio Diagnostics to help diagnose Alzheimer’s disease has ...

The US Food and Drug Administration (FDA) has approved the first blood test for diagnosing Alzheimer’s disease.1 The test, called Lumipulse, was granted breakthrough device approval and is designed ...

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and ...

A highly sensitive real-time PCR-based systems helps scientists rapidly detect microbial contamination in cell therapy ...

New tools for computer-aided retrosynthesis help scientists streamline route planning, reducing the financial and environmental costs of drug development.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...

Not everyone will experience difficulties with all of these activities and a person’s symptoms can progress at different rates. You can find information about how dementia commonly affects activities ...